KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,068,810 | -79.3% | 61,532 | -83.2% | 0.00% | -75.0% |
| Q2 2023 | $5,167,008 | +225.2% | 366,975 | +148.5% | 0.01% | +166.7% |
| Q1 2023 | $1,588,961 | -50.7% | 147,673 | -31.4% | 0.00% | -40.0% |
| Q4 2022 | $3,222,482 | +1059.2% | 215,119 | +890.6% | 0.01% | – |
| Q3 2022 | $278,000 | +33.0% | 21,715 | +0.4% | 0.00% | – |
| Q2 2022 | $209,000 | -3.7% | 21,636 | -1.0% | 0.00% | – |
| Q1 2022 | $217,000 | -16.5% | 21,858 | -1.2% | 0.00% | – |
| Q4 2021 | $260,000 | – | 22,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,025,000 | $12,064,000 | 2.56% |
| GREAT POINT PARTNERS LLC | 536,738 | $6,317,000 | 1.40% |
| Endurant Capital Management LP | 244,125 | $2,873,000 | 0.69% |
| HHLR ADVISORS, LTD. | 2,920,023 | $34,369,000 | 0.53% |
| Integral Health Asset Management, LLC | 140,000 | $1,648,000 | 0.46% |
| Spearhead Capital Advisors, LLC | 235,024 | $2,766,000 | 0.33% |
| Jackson Creek Investment Advisors LLC | 77,069 | $907,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 712,807 | $8,390,000 | 0.30% |
| Parkman Healthcare Partners LLC | 113,644 | $1,338,000 | 0.30% |
| Birchview Capital, LP | 30,000 | $353,000 | 0.23% |